Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular region. (Q53428359)

14 May 2018

title

Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular region. (English)

1 reference

14 May 2018

1 reference

cervix uterine cancer

1 reference

Yi Zheng

1

1 reference

14 May 2018

Yijuan Zhang

2

1 reference

14 May 2018

Yuandong Ma

3

1 reference

14 May 2018

Jun Wan

4

1 reference

14 May 2018

Chaofan Shi

5

1 reference

14 May 2018

Laiqiang Huang

6

1 reference

14 May 2018

publication date

24 December 2008

1 reference

14 May 2018

The Journal of Microbiology

published in

1 reference

14 May 2018

volume

46

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

page(s)

728-736

1 reference

14 May 2018

The role of the CD28 receptor during T cell responses to antigen

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12275-008-0087-1

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12275-008-0087-1

Vaccines against human papillomavirus and cervical cancer: promises and challenges

21 January 2018

1 reference

12 December 2020

Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4

1 reference

12 December 2020

SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling

1 reference

12 December 2020

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.

1 reference

12 December 2020

Progress on new vaccine strategies for the immunotherapy and prevention of cancer

1 reference

12 December 2020

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

12 December 2020

Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.

1 reference

12 December 2020

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

12 December 2020

Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.

1 reference

12 December 2020

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

1 reference

12 December 2020

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1 reference

12 December 2020

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

1 reference

12 December 2020

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

1 reference

12 December 2020

The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors.

1 reference

12 December 2020

Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein

1 reference

12 December 2020

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

12 December 2020

Enhanced antitumor immunity by fusion of CTLA-4 to a self tumor antigen

1 reference

12 December 2020

Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia

1 reference

12 December 2020

Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

1 reference

12 December 2020

Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4.

1 reference

12 December 2020

Adjuvant-independent immunization by immunotargeting antigens to MHc and non-MHc determinants in vivo

1 reference

12 December 2020

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

12 December 2020

Pathogenesis of human papillomaviruses in differentiating epithelia

1 reference

12 December 2020

Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.

1 reference

12 December 2020

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

12 December 2020

Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Enhanced antigen immunogenicity induced by bispecific antibodies

1 reference

12 December 2020

CTLA4Ig: bridging the basic immunology with clinical application

1 reference

12 December 2020

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

12 December 2020

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

12 December 2020

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

12 December 2020

Human papillomavirus in cervical and head-and-neck cancer

1 reference

12 December 2020

A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients

1 reference

12 December 2020

10.1007/S12275-008-0087-1

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018